Enorama Pharma AB (ERMA) — Capital Reinvestment Ratio
Enorama Pharma AB (ERMA) has a Capital Reinvestment Ratio of 4.15x as of December 2015, meaning it reinvests 4% of its operating cash flow (Skr480.00K) in capital expenditures (Skr1.99 Million). See Enorama Pharma AB balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Enorama Pharma AB Capital Reinvestment Ratio (2014–2015)
This chart tracks Enorama Pharma AB's Capital Reinvestment Ratio across 2 annual periods. Check ERMA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Enorama Pharma AB (2014–2015)
Year-by-year Capital Reinvestment Ratio for Enorama Pharma AB from 2014 to 2015. For live market cap and broader valuation context, see Enorama Pharma AB market capitalisation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 4.15x | Skr480.00K | Skr1.99 Million | ▼ -7.8% |
| 2014 | 4.50x | Skr307.00K | Skr1.38 Million | — |